HCW Biologics Inc.
HCWB
$2.06
$0.073.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 136.36% | 29.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 136.36% | 29.41% | |||
| Cost of Revenue | 140.38% | 26.83% | |||
| Gross Profit | 138.46% | 30.00% | |||
| SG&A Expenses | -15.33% | -9.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.69% | -12.60% | |||
| Operating Income | 4.97% | 12.65% | |||
| Income Before Tax | -136.26% | 12.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -136.26% | 12.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -136.26% | 12.25% | |||
| EBIT | 4.97% | 12.65% | |||
| EBITDA | 1.70% | 10.56% | |||
| EPS Basic | 70.31% | -245.04% | |||
| Normalized Basic EPS | 23.13% | 45.04% | |||
| EPS Diluted | 70.31% | -245.04% | |||
| Normalized Diluted EPS | 23.13% | 45.04% | |||
| Average Basic Shares Outstanding | 26.96% | 59.38% | |||
| Average Diluted Shares Outstanding | 26.96% | 59.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||